Anixa Biosciences, Inc.ANIXNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank43
Studio
Year-over-Year Change

Return on equity

Latest
-72.07%
↑ 49% vs avg
Percentile
P43
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
-142.54%
Historical baseline
PeriodValueYoY Change
2025-72.07%-14.8%
2024-62.78%-55.7%
2023-40.31%+13.9%
2022-46.80%-28.1%
2021-36.53%+68.4%
2020-115.65%+48.0%
2019-222.47%+13.6%
2018-257.53%-307.3%
2017-63.22%+87.6%
2016-508.01%-